128 related articles for article (PubMed ID: 23527518)
1. The influence of family history on cognitive heuristics, risk perceptions, and prostate cancer screening behavior.
McDowell ME; Occhipinti S; Chambers SK
Health Psychol; 2013 Nov; 32(11):1158-69. PubMed ID: 23527518
[TBL] [Abstract][Full Text] [Related]
2. Online prostate cancer screening decision aid for at-risk men: a randomized trial.
Watts KJ; Meiser B; Wakefield CE; Barratt AL; Howard K; Cheah BC; Mann GJ; Lobb EA; Gaff CL; Patel MI
Health Psychol; 2014 Sep; 33(9):986-97. PubMed ID: 24274808
[TBL] [Abstract][Full Text] [Related]
3. Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study.
Kirkegaard P; Edwards A; Nielsen TLO; Ørntoft TF; Sørensen KD; Borre M; Bro F
BMC Fam Pract; 2018 Feb; 19(1):32. PubMed ID: 29454309
[TBL] [Abstract][Full Text] [Related]
4. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
[TBL] [Abstract][Full Text] [Related]
5. A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: implications for PSA testing.
Forbat L; Place M; Kelly D; Hubbard G; Boyd K; Howie K; Leung HY
BJU Int; 2013 Mar; 111(3):389-95. PubMed ID: 23030810
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
Psychooncology; 2013 Nov; 22(11):2496-504. PubMed ID: 23712946
[TBL] [Abstract][Full Text] [Related]
7. Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
BJU Int; 2012 Apr; 109 Suppl 3():64-70. PubMed ID: 22458497
[TBL] [Abstract][Full Text] [Related]
8. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of Prostate Cancer Screening Controversy and Informed Decision Making: Implications for Development of a Targeted Decision Aid for Unaffected Male First-Degree Relatives.
Gwede CK; Davis SN; Wilson S; Patel M; Vadaparampil ST; Meade CD; Rivers BM; Yu D; Torres-Roca J; Heysek R; Spiess PE; Pow-Sang J; Jacobsen P
Am J Health Promot; 2015; 29(6):393-401. PubMed ID: 24968183
[TBL] [Abstract][Full Text] [Related]
10. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
11. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
13. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Baade PD; Steginga SK
Eur J Cancer Care (Engl); 2009 Nov; 18(6):545-55. PubMed ID: 19686273
[TBL] [Abstract][Full Text] [Related]
14. The role of the affect heuristic and cancer anxiety in responding to negative information about medical tests.
Scherer LD; Shaffer VA; Caverly T; Scherer AM; Zikmund-Fisher BJ; Kullgren JT; Fagerlin A
Psychol Health; 2018 Feb; 33(2):292-312. PubMed ID: 28535696
[TBL] [Abstract][Full Text] [Related]
15. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
16. Informed decision making on PSA testing for the detection of prostate cancer: an evaluation of a leaflet with risk indicator.
van Vugt HA; Roobol MJ; Venderbos LD; Joosten-van Zwanenburg E; Essink-Bot ML; Steyerberg EW; Bangma CH; Korfage IJ
Eur J Cancer; 2010 Feb; 46(3):669-77. PubMed ID: 20022239
[TBL] [Abstract][Full Text] [Related]
17. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
[TBL] [Abstract][Full Text] [Related]
18. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients.
Vadaparampil ST; Jacobsen PB; Kash K; Watson IS; Saloup R; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):753-8. PubMed ID: 15159306
[TBL] [Abstract][Full Text] [Related]
19. The psychological impact of undergoing genetic-risk profiling in men with a family history of prostate cancer.
Bancroft EK; Castro E; Bancroft GA; Ardern-Jones A; Moynihan C; Page E; Taylor N; Eeles RA; Rowley E; Cox K
Psychooncology; 2015 Nov; 24(11):1492-9. PubMed ID: 25872100
[TBL] [Abstract][Full Text] [Related]
20. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Li J; Zhao G; Hall IJ
Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
